enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO)

CUSIP: 29415J106

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, $0.00001 par value
Shares outstanding
20,505,656
Total 13F shares
5,079,935
Share change
+1,439,554
Total reported value
$20,269,051
Put/Call ratio
0%
Price per share
$3.99
Number of holders
36
Value change
+$6,075,451
Number of buys
19
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 29415J106?
CUSIP 29415J106 identifies NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
4.2%
859,261
$2,259,856 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
2.9%
600,906
$1,580,383 31 Mar 2025
13F
Nantahala Capital Management, LLC
13F
Company
2.9%
594,661
$1,563,958 31 Mar 2025
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
1.4%
296,031
$778,562 31 Mar 2025
13F
Westside Investment Management, Inc.
13F
Company
1.3%
259,050
$681,309 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.96%
197,298
$518,965 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.95%
194,213
$510,780 31 Mar 2025
13F
Altium Capital Management LLC
13F
Company
0.6%
123,256
$324,163 31 Mar 2025
13F
Dauntless Investment Group, LLC
13F
Company
0.35%
70,848
$186,330 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.32%
65,964
$173,485 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.3%
60,608
$159,399 31 Mar 2025
13F
Squarepoint Ops LLC
13F
Company
0.2%
41,438
$108,982 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.2%
40,800
$107,304 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.2%
40,129
$105,539 31 Mar 2025
13F
Fermata Advisors, LLC
13F
Company
0.19%
39,399
$103,619 31 Mar 2025
13F
XTX Topco Ltd
13F
Company
0.15%
30,437
$80,049 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
26,421
$69,487 31 Mar 2025
13F
Laird Norton Wetherby Trust Company, LLC
13F
Company
0.12%
25,000
$65,750 31 Mar 2025
13F
HOHIMER WEALTH MANAGEMENT, LLC
13F
Company
0.1%
20,000
$52,600 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.08%
16,119
$42,393 31 Mar 2025
13F
Tamar Securities, LLC
13F
Company
0.07%
13,990
$36,794 31 Mar 2025
13F
Sanctuary Advisors, LLC
13F
Company
0.06%
12,000
$31,560 31 Mar 2025
13F
UBS Group AG
13F
Company
0.05%
10,771
$28,327 31 Mar 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.04%
8,284
$21,787 31 Mar 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
2,002
$5,265 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
1,604
$4,218 31 Mar 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0%
860
$1,823 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0%
625
$1,643 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
250
$657 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
150
$394 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
6
$16 31 Mar 2025
13F
Jennifer Bright
3/4/5
Chief Financial Officer
class O/S missing
350,000
19 May 2025
Craig Glynn
3/4/5
Chief Financial Officer
class O/S missing
75,000
05 Dec 2023

Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q2 2025

As of 30 Jun 2025, enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,079,935 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., VANGUARD GROUP INC, Nantahala Capital Management, LLC, Westside Investment Management, Inc., OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), Universal- Beteiligungs- und Servicegesellschaft mbH, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, and MORGAN STANLEY. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
30
Q2 2025 holders
36
Holder diff
6
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .